BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 16887241)

  • 1. Studies on immunogenicity and protective efficacy of DnaJ of Salmonella Typhi against lethal infection by Salmonella Typhimurium in mice.
    Sagi SS; Paliwal P; Bansal A; Mishra C; Khan N; Mustoori SR; Ilavazhagan G; Sawhney RC; Banerjee PK
    Vaccine; 2006 Nov; 24(49-50):7135-41. PubMed ID: 16887241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice.
    Paliwal PK; Bansal A; Sagi SS; Mustoori S; Govindaswamy I
    Clin Immunol; 2008 Jan; 126(1):89-96. PubMed ID: 18024219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and protective efficacy of DnaJ (hsp40) of Streptococcus pneumoniae against lethal infection in mice.
    Khan MN; Bansal A; Shukla D; Paliwal P; Sarada SK; Mustoori SR; Banerjee PK
    Vaccine; 2006 Sep; 24(37-39):6225-31. PubMed ID: 16797798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
    Nagarajan AG; Balasundaram SV; Janice J; Karnam G; Eswarappa SM; Chakravortty D
    Vaccine; 2009 May; 27(21):2804-11. PubMed ID: 19428891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella Typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection.
    Paliwal PK; Bansal A; Sagi SS; Sairam M
    Vaccine; 2011 Sep; 29(38):6532-9. PubMed ID: 21767594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
    Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma interferon-independent effects of interleukin-12 on immunity to Salmonella enterica serovar Typhimurium.
    Price JD; Simpfendorfer KR; Mantena RR; Holden J; Heath WR; van Rooijen N; Strugnell RA; Wijburg OL
    Infect Immun; 2007 Dec; 75(12):5753-62. PubMed ID: 17875635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
    Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
    Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salmonella enterica serovar Choleraesuis derivatives harbouring deletions in rpoS and phoP regulatory genes as vehicles for DNA vaccines.
    Bartolomé A; Herrero-Gil A; Horcajo P; Orden JA; de Fuente R; Domínguez-Bernal G
    Vet Microbiol; 2010 Feb; 141(1-2):81-8. PubMed ID: 19720478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model.
    Negi VD; Singhamahapatra S; Chakravortty D
    Vaccine; 2007 Jul; 25(29):5315-23. PubMed ID: 17574312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cellular immune response and anti-Salmonella enterica serovar typhi bactericidal antibodies in healthy volunteers by immunization with a vaccine candidate against typhoid fever.
    Salazar-González RM; Maldonado-Bernal C; Ramírez-Cruz NE; Rios-Sarabia N; Beltrán-Nava J; Castañón-González J; Castillo-Torres N; Palma-Aguirre JA; Carrera-Camargo M; López-Macías C; Isibasi A
    Immunol Lett; 2004 May; 93(2-3):115-22. PubMed ID: 15158606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
    Qu D; Wang S; Cai W; Du A
    Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stable expression and immunogenicity in a attenuated Salmonella typhi strain of coli surface antigen-6 of enterotoxigenic Escherichia coli].
    Teng J; Rui X; Zhang Y; Zhang Z; Su G
    Wei Sheng Wu Xue Bao; 1999 Dec; 39(6):533-8. PubMed ID: 12555559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction, safety and immunogenicity analysis of attenuated salmonella typhimurium harbouring TGEV DNA vaccine].
    Yang H; Liu J; Cao S; Huang X; Wen X
    Wei Sheng Wu Xue Bao; 2009 Jan; 49(1):72-7. PubMed ID: 19388267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Salmonella typhimurium infections in rats. II. Active and passive immunization as protection against a lethal bacterial dose.
    Hougen HP; Jensen ET; Klausen B
    APMIS; 1990 Jan; 98(1):30-6. PubMed ID: 2405888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
    McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response induced by Salmonella typhimurium defective in ppGpp synthesis.
    Na HS; Kim HJ; Lee HC; Hong Y; Rhee JH; Choy HE
    Vaccine; 2006 Mar; 24(12):2027-34. PubMed ID: 16356600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immune responses and protective efficacy against infection with Mycobacterium tuberculosis induced by Hsp65 and hIL-2 fusion protein in mice.
    Shi C; Yuan S; Zhang H; Zhang T; Wang L; Xu Z
    Scand J Immunol; 2009 Feb; 69(2):140-9. PubMed ID: 19144078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the abilities of Salmonella typhimurium rpoS, aroA and rpoS aroA strains to elicit humoral immune responses in BALB/c mice and to cause lethal infection in athymic BALB/c mice.
    Coynault C; Norel F
    Microb Pathog; 1999 Jun; 26(6):299-305. PubMed ID: 10343058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.